UPEXI, INC. (UPXI): Nasdaq/NYSE listing notice — Upexi receives Nasdaq bid price deficiency notice; faces potential delisting if not cured by Sep 30, 2024

UPEXI, INC.

Stock closed below $1.00 for 30 consecutive business days as of April 1, 2024.
Company has until September 30, 2024 to regain compliance with the minimum bid price requirement.
Considering a reverse stock split and other options to cure the deficiency.
No immediate effect on listing or trading of common stock; Nasdaq letter is a deficiency notice.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

UPEXI, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 1, 2024, Upexi, Inc. (the “ Company ”) received a letter (the “ Nasdaq Bid Price Letter ”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for thirty consecutive business days prior to the date thereof, the bid price for the Company’s common stock (the “ Common Stock ”) had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Price Requirement ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days

View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

UPEXI, INC. filing history →

Source: SEC EDGAR

accession 0001477932-24-001778

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.